2Y1Y
Human alphaB crystallin ACD(residues 71-157)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I02 |
Synchrotron site | Diamond |
Beamline | I02 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2009-05-09 |
Detector | ADSC CCD |
Spacegroup name | P 43 2 2 |
Unit cell lengths | 36.030, 36.030, 148.320 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 35.012 - 2.000 |
R-factor | 0.2051 |
Rwork | 0.204 |
R-free | 0.22110 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2wj7 |
RMSD bond length | 0.003 |
RMSD bond angle | 0.673 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | PHENIX ((PHENIX.REFINE)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 35.010 | 2.110 |
High resolution limit [Å] | 2.000 | 2.000 |
Rmerge | 0.100 | 0.320 |
Number of reflections | 7272 | |
<I/σ(I)> | 25.6 | 11.6 |
Completeness [%] | 100.0 | 100 |
Redundancy | 25.4 | 26.8 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 9 | SITTING DROPS, 20 MG/ML PROTEIN IN 25 MM TRIS, PH8.5, 200 MM NACL. EQUILIBRATED AGAINST MOTHER LIQUOR OF 110 MM BICINE, PH 9.0, 40% MPD |